Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.6101
H.R.6101: Drug Price Transparency in Medicaid Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Dec. 1, 2021
- Latest Major Action Dec. 2, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
4 (1 Democrat, 3 Republicans)
Bill Version
- Introduced in House - Dec. 1, 2021
Bill Summary
Drug Price Transparency in Medicaid Act of 2021 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Dec. 2, 2021 |
Referred to the Subcommittee on Health.
|
Dec. 1, 2021 |
Referred to the House Committee on Energy and Commerce.
|
Dec. 1, 2021 |
Introduced in the House by Buddy Carter (R-Ga.) |